A six week double blind, placebo controlled, crossover study of the effect of misoprostol in the treatment of aspirin sensitive asthma

Thorax

Volumn 54, Issue 10, 1999, Pages 900-904

  Wasiak, Wojciech ^a   Szmidt, Mirosław ^a  

^a Inst of TB/Lung Disease in Warsaw   (Poland)

Author keywords

Aspirin sensitive asthma; Misoprostol; Prostaglandin E1

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; MISOPROSTOL;

ADULT; AGED; ARTICLE; ASTHMA; BLOOD CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEFECATION; DOUBLE BLIND PROCEDURE; DRUG HYPERSENSITIVITY; EOSINOPHIL; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RHINORRHEA;

EID: 0032872827     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.10.900     Document Type: Article

References (29)

1. 4 release from activated neutrophils. Proc Natl Acad Sci USA 1989;80:4349-53.
2. Hogaboam CM, Bissonnette EY, Chin BC, et al. Prostaglandins inhibit inflammatory mediator release from rat mast cells. Gastroenterology 1993;104:122-9.
3. Kuehl FA, Dougherty HW, Ham EA. Interactions between prostaglandins and leukotrienes. Biochem Pharmacol 1984;33:1-5.
4. Marone G, Kagey-Sobotka A, Lichtenstein LM. Effects of arachidonic acid and its metabolites on antigen-induced histamine release From human basophils in vitro. J Immunol 1979;123:1699-77.
5. 2: apparent correlation with in vivo modulation of mediator release. Proc Natl Acad Sci USA 1988;85:2315-9.
6. Tauber AJ. Immunologic release of histamine and slow reacting substance of anaphylaxis from human lung. Effect of prostaglandins on release of histamine. J Immunol 1973;111:27-32.
7. Gold KN, Weyand CM, Goronzy JJ. Modulation of helper T cell function by prostaglandins. Arthritis Rheum 1994;37:925-33.
8. 3 1992;76:251-7.
9. 2 on eicosanoid release by human bronchial biopsy specimens from normal and inflamed mucosa. Thorax 1996;51:919-23.
10. Alam R, Dejarnatt A, Stafford S, et al. Selective inhibition of the cutaneous late but not immediate allergic response to antigens by misoprostol, a PGE analog. Am Rev Respir Dis 1993;148:1066-70.
11. 1. Prostaglandins 1994;48:187-95.
12. Pavord ID, Tattersfield AE. Bronchoprotective role for endogenous prostaglandin E2. Lancet 1995;345:436-8.
13. Szczeklik A, Aspirin-induced asthma as a viral disease. Clin Allergy 1988;18:15-20.
14. 2 on allergen-induced asthma. Am Rev Respir Dis 1993;148:87-90.
15. 2 against ultrasonically nebulized distilled water-induced bronchoconstriction. Eur Resp J 1996;9(Suppl 23):33S.
16. 2 on bronchial reactivity to sodium metabi-sulphite and methacholine in patients with asthma. Thorax 1991;46:633-7.
17. 2 on exercise-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 1994;149:1138-41.
18. 1) on postaspirin bronchoconstriction in aspirin sensitive asthmatics. J Invest Allergol Clin Immunol 1996;6:121-5.
19. Szczeklik A, Mastalerz L, Ni¿ankowska E, et al. Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. Am J Respir Crit Care Med 1996;153:567-71.
20. 4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 1996;153:572-5.
21. Taniguchi M, Sakakibara H, Suetsugu S, et al. Subbioactive dose of PGE especially inhibits aspirin induced attacks in patients with aspirin-sensitive asthma (abstract). Allergy 1996;51(Suppl):84.
22. Graham DY, Agrawal NM, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet 1988;ii:1277-80.
23. Smallwood JI, Malavista SE. Misoprostol stimulates leukocyte cyclic adenosine 3′,5′-monophosphate production and synergizes with colchicine: novel combination of established drugs may boost anti-inflammatory potential. J Pharmacol Exp Ther 1994;269:1196-204.
24. Wheeldon A, Vardey CJ. Characterization of the inhibitory prostanoid receptors on human neutrophils. Br J Pharmacol 1993;108:1051-4.
25. National Heart, Lung and Blood Institute, National Institutes of Health. Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report. Publication No. 95-3659, 1995.
26. Phillips GD, Foord R, Holgate ST. Inhaled lysine-aspirin as a bronchoprovocation procedure in aspirin-sensitive asthma: its repeatability, absence of late-phase reaction, and the role of histamine. J Allergy Clin Immunol 1989;84:232-41.
27. Grzelewska-Rzymowska I, Ro¿niecki J, Szmidt M. Nadwra¿liwoœæ na aspirynê i inne niesteroidowe leki przeciwzaplne - metody ujawniania nadwra¿liwoœci i wytwarzania stanu tolerancji. Pol Arch Med Wewn 1989;81:107-13.
28. 4 after lysine-aspirin inhalation in asthmatic subjects. Am Rev Respir Dis 1992;146:1531-1.
29. 4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991;143:1025-9.